This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Harvard College, Zikani Therapeutics, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,071 
1 out of 1 Years Active: 2026
Title: Andre Sanchez: Innovator in Macrolide Development
Introduction
Andre Sanchez is a notable inventor based in Bradenton, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrolides for treating infectious diseases. His innovative work has the potential to impact the medical community positively.
Latest Patents
Andre Sanchez holds a patent for "C10-alkylene substituted 13-membered macrolides and uses thereof." This patent describes 13-membered macrolides that are specifically designed for the treatment of infectious diseases. The macrolides detailed in his patent are azaketolides, which are crucial for addressing infections caused by Gram-negative bacteria. The patent also outlines methods for preparing these macrolides and pharmaceutical compositions that incorporate them.
Career Highlights
Throughout his career, Andre has worked with prestigious institutions, including Harvard College and Zikani Therapeutics, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical field.
Collaborations
Andre has collaborated with talented individuals such as Shuhao Shi and Thrimurtulu Neetipalli, who have contributed to his research endeavors. Their combined expertise has enhanced the development of innovative solutions in the treatment of infectious diseases.
Conclusion
Andre Sanchez is a pioneering inventor whose work in macrolide development showcases his commitment to advancing medical treatments. His contributions are vital in the ongoing fight against infectious diseases, and his patent reflects the innovative spirit that drives progress in the pharmaceutical industry.